Prognostic Factors for Progression in Patients (pts) with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL) in Complete Molecular Response (CMR) within 3 Months of Therapy with Tyrosine Kinase Inhibitors (TKIs)

被引：2

作者：

Sasaki, Koji ^{[1
]}

Kantarjian, Hagop M. ^{[1
]}

Samra, Bachar ^{[1
]}

Short, Nicholas J. ^{[2
]}

Khoury, Joseph D. ^{[3
]}

Kanagal-Shamanna, Rashmi ^{[3
]}

Konopleva, Marina Y. ^{[1
]}

Jain, Nitin ^{[1
]}

DiNardo, Courtney D. ^{[1
]}

Khouri, Rita ^{[1
]}

Garcia-Manero, Guillermo ^{[1
]}

Kadia, Tapan M. ^{[1
]}

Wierda, William G. ^{[1
]}

Tippett, Nicole ^{[1
]}

Garris, Rebecca ^{[1
]}

Jeanis, Victoria ^{[1
]}

Daver, Naval G. ^{[1
]}

Thompson, Philip A. ^{[1
]}

Yilmaz, Musa ^{[1
]}

Cortes, Jorge E. ^{[1
]}

O'Brien, Susan M. ^{[4
]}

Ravandi, Farhad ^{[1
]}

Jabbour, Elias ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[4] Univ Calif Irvine Hlth, Div Hematol Oncol, Dept Med, Chao Family Comprehens Canc Ctr, Orange, CA USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-128619

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：6

共 50 条

[1] Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors
Sasaki, Koji
Kantarjian, Hagop M.
Short, Nicholas J.
Samra, Bachar
Khoury, Joseph D.
Kanagal Shamanna, Rashmi
Konopleva, Marina
Jain, Nitin
DiNardo, Courtney D.
Khouri, Rita
Garcia-Manero, Guillermo
Kadia, Tapan M.
Wierda, William G.
Khouri, Issa F.
Kebriaei, Partow
Mehta, Rohtesh S.
Champlin, Richard E.
Garris, Rebecca
Cheung, Cora Marie
Daver, Naval
Thompson, Philip A.
Yilmaz, Musa
Ravandi, Farhad
Jabbour, Elias
CANCER, 2021, 127 (15) : 2648 - 2656
[2] Discontinuation of Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL)
Samra, Bachar
Kantarjian, Hagop M.
Sasaki, Koji
Konopleva, Marina Y.
Khouri, Rita
O'Brien, Susan M.
Ferrajoli, Alessandra
Nunez, Cesar
Kadia, Tapan M.
Jabbour, Elias
BLOOD, 2019, 134
[3] Outcome of Patients (Pts) with Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL) without 3-Month Complete Molecular Response (CMR)
Samra, Bachar
Kantarjian, Hagop M.
Sasaki, Koji
Short, Nicholas J.
Khouri, Rita
Khoury, Joseph D.
Champlin, Richard E.
Kebriaei, Partow
Cortes, Jorge E.
Jorgensen, Jeffrey L.
Wang, Sa A.
Garcia-Manero, Guillermo
Kadia, Tapan M.
Borthakur, Gautam M.
Verstovsek, Srdan
Daver, Naval G.
Montalban-Bravo, Guillermo
Jain, Nitin
Konopleva, Marina Y.
Yilmaz, Musa E.
Naqvi, Kiran
O'Brien, Susan M.
Ravandi, Farhad
Jabbour, Elias
BLOOD, 2019, 134
[4] Results of Treatment with Tyrosine Kinase Inhibitors(TKIs) in Combination with Intensive Chemotherapy in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia(Ph plus ALL)
Kyo, Taiichi
Okatani, Takeshi
Kyo, Kouhei
Imanaka, Ryouta
Itagaki, Mitsuhiro
Katayama, Yuuta
Iwato, Koji
Asaoku, Hideki
BLOOD, 2011, 118 (21) : 652 - 652
[5] Impact of complete molecular response (CMR) on survival in patients with Philadelphia chromosome positive (Ph plus ) acute lymphoblastic leukemia (ALL).
Short, Nicholas James
Jabbour, Elias
Cortes, Jorge E.
Garris, Rebecca
O'Brien, Susan Mary
Patel, Keyur
Sasaki, Koji
Issa, Ghayas C.
Garcia-Manero, Guillermo
Thomas, Deborah A.
Kantarjian, Hagop M.
Ravandi, Farhad
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[6] Outcomes of Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Molecular Response at Three Months of Therapy
Sasaki, Koji
Kantarjian, Hagop
Samra, Bachar
Short, Nicholas
Khoury, Joseph
Kanagal, Rashmi
Konopleva, Marina
Jain, Nitin
DiNardo, Courtney
Khouri, Rita
Garcia-Manero, Guillermo
Kadia, Tapan
Wierda, William
Tippett, Nicole
Garris, Rebecca
Jeanis, Vicki
Daver, Naval
Thompson, Philip
Yilmaz, Musa
Cortes, Jorge
O'Brien, Susan
Ravandi, Farhad
Jabbour, Elias
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S164 - S165
[7] Managing Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitors
Ravandi, Farhad
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (02): : 198 - 203
[8] Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Mathisen, Michael S.
O'Brien, Susan
Thomas, Deborah
Cortes, Jorge
Kantarjian, Hagop
Ravandi, Farhad
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (03) : 187 - 194
[9] Patterns of Relapse in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Who Achieve Complete Molecular Response with Chemotherapy Plus a Tyrosine Kinase Inhibitor
Short, Nicholas J.
Ravandi, Farhad
Cortes, Jorge E.
Garris, Rebecca
O'Brien, Susan M.
Patel, Keyur P.
Jorgensen, Jeffrey L.
Khoury, Joseph D.
Garcia-Manero, Guillermo
Thomas, Deborah A.
Kantarjian, Hagop M.
Jabbour, Elias J.
BLOOD, 2016, 128 (22)
[10] Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia
Piccaluga, Pier Paolo
Paolini, Stefania
Martinelli, Giovanni
CANCER, 2007, 110 (06) : 1178 - 1186

← 1 2 3 4 5 →